At the Center of It All
“Our people are at the heart of everything we do to advance care for cancer patients. Our ADCT team is the most important asset of our company. I am committed to ensuring we provide meaningful health and wellness support so that each employee is at their best both professionally and personally”
Ameet Mallik
Chief Executive Officer
“I believe People are ADCT’s greatest asset. Providing our employees comprehensive benefits stems from the belief that we should consider the physical, mental, emotional, and financial well-being of our team. Not just because it provides a better economic or productivity outcome for the company, but because it’s just the right thing to do if you genuinely care about people”
Kim Pope
Chief People Officer
Our Vision
We strive to be a leading antibody drug conjugate company that transforms the lives of those impacted by cancer. To achieve this, we strive to transform treatment for patients through our focused portfolio with ZYNLONTA (loncastuximab tesirine-lpyl) and an early stage PSMA-targeting ADC. We are a pioneer in the ADC field focused on driving innovation in ADC development with specialized capabilities from clinical to manufacturing and commercialization.





